Trials / Completed
CompletedNCT04178317
A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice
Venetoclax (Venclexta Tablet) Post-Marketing Surveillance for CLL Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 14 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This observational study will evaluate the safety and effectiveness of Venetoclax used in routine clinical practice for participants diagnosed with chronic lymphocytic leukemia (CLL).
Conditions
Timeline
- Start date
- 2020-04-02
- Primary completion
- 2025-08-18
- Completion
- 2025-08-18
- First posted
- 2019-11-26
- Last updated
- 2025-12-04
Locations
13 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04178317. Inclusion in this directory is not an endorsement.